This page shows the latest atrial fibrilliation news and features for those working in and with pharma, biotech and healthcare.
The ARISTOTLE trial, which involved 18, 201 patients with atrial fibrillation and at least one risk factor for stroke, demonstrated a 21 per cent reduced risk of stroke or systemic embolism ... Dr Christopher B Granger, the lead investigator for the trial
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...